Cann American Corp. (CNNA) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The company is headquartered in Cloverdale, CA, United States. The current CEO is Jason R. Tucker.
CNNA has IPO date of 2011-02-14, 1 full-time employees, listed on the Other OTC, a market capitalization of $1.11M.
Cann American Corp., a development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was founded in 2004 and is based in Cloverdale, California.
